Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (121-130 of 611) with videos related to

Pageof 62
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsyJ A Girault, R Raisman-Vozari, Y Agid, et al.
Life Sciences|August 12, 1985
Adrenergic receptors on cerebral microvessels in control and parkinsonian subjectsR Cash, F Lasbennes, R Sercombe, et al.
Psychopharmacology. Supplementum|January 1, 1985
Pathophysiology of L-dopa-induced abnormal involuntary movementsY Agid, A M Bonnet, M Ruberg, et al.
Brain : a Journal of Neurology|August 4, 1999
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's diseaseP Damier, E C Hirsch, Y Agid, et al.
Neurology|January 1, 1990
Age-induced cognitive disturbances in Parkinson's diseaseB Dubois, B Pillon, N Sternic, et al.
Brain Research|April 2, 1986
Cellular localization of adrenergic receptors in rat and human brainR Cash, R Raisman, L Lanfumey, et al.
Neurology|June 1, 1996
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's diseaseA F Carpentier, A M Bonnet, M Vidailhet, et al.
Revue Neurologique|January 1, 1982
[Effect of a synthetic analog of enkephalin on the choreic syndrome]A Destée, H Petit, P Warot, et al.
Lancet (London, England)|February 4, 1984
Striatal glutamate decarboxylase values, indicative of hospital where patient diedY Agid, A Ploska, J C Monfort, et al.
Brain Research|August 30, 1973
Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificityY Agid, F Javoy, J Glowinski, et al.
Pageof 62

Showing results (121-130 of 611) with videos related to

Sort By:
Pageof 62
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsyJ A Girault, R Raisman-Vozari, Y Agid, et al.
Life Sciences|August 12, 1985
Adrenergic receptors on cerebral microvessels in control and parkinsonian subjectsR Cash, F Lasbennes, R Sercombe, et al.
Psychopharmacology. Supplementum|January 1, 1985
Pathophysiology of L-dopa-induced abnormal involuntary movementsY Agid, A M Bonnet, M Ruberg, et al.
Brain : a Journal of Neurology|August 4, 1999
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's diseaseP Damier, E C Hirsch, Y Agid, et al.
Neurology|January 1, 1990
Age-induced cognitive disturbances in Parkinson's diseaseB Dubois, B Pillon, N Sternic, et al.
Brain Research|April 2, 1986
Cellular localization of adrenergic receptors in rat and human brainR Cash, R Raisman, L Lanfumey, et al.
Neurology|June 1, 1996
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's diseaseA F Carpentier, A M Bonnet, M Vidailhet, et al.
Revue Neurologique|January 1, 1982
[Effect of a synthetic analog of enkephalin on the choreic syndrome]A Destée, H Petit, P Warot, et al.
Lancet (London, England)|February 4, 1984
Striatal glutamate decarboxylase values, indicative of hospital where patient diedY Agid, A Ploska, J C Monfort, et al.
Brain Research|August 30, 1973
Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificityY Agid, F Javoy, J Glowinski, et al.
Pageof 62